The effect of modafinil on counter-regulatory and cognitive responses to hypoglycaemia

Diabetologia

Volumn 47, Issue 10, 2004, Pages 1704-1711

  Smith, D ^a   Pernet, A ^a   Rosenthal, J M ^a   Bingham, E M ^a   Reid, H ^a   Macdonald, I A ^b   Amiel, S A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Cognitive function; Gamma aminobutyric acid; Hypoglycaemia; Modafinil

Indexed keywords

ADRENALIN; GLUCAGON; GLUCOSE; GROWTH HORMONE; HYDROCORTISONE; MODAFINIL;

ACCURACY; ADRENALIN BLOOD LEVEL; ARTICLE; AUTONOMIC DYSFUNCTION; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; HEART RATE; HORMONE RESPONSE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; HYPOGLYCEMIA; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TASK PERFORMANCE;

ADULT; BENZHYDRYL COMPOUNDS; BLOOD GLUCOSE; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION; DOUBLE-BLIND METHOD; EPINEPHRINE; GLUCAGON; GLUCOSE CLAMP TECHNIQUE; HEART RATE; HUMANS; HYPOGLYCEMIA; MALE; PLACEBOS; REACTION TIME; REFERENCE VALUES;

EID: 11144328138     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-004-1513-5     Document Type: Article

References (40)

1. Borg WP, During MJ, Sherwin RS, Borg MA, Brines ML, Shulman GI (1994) Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycaemia. J Clin Invest 93:1677-1682
2. Borg WP, Sherwin RS, During MJ, Borg MA, Shulman GI (1995) Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release. Diabetes 44:180-184
3. Borg MA, Sherwin RS, Borg WP, Tamborlane WV, Shulman GI (1997) Local ventromedial hypothalamus glucose perfusion blocks counter-regulation during systemic hypoglycaemia in awake rats. J Clin Invest 99:361-365
4. Leloup C, Arluison M, Lepetit N et al. (1994) Glucose transporter 2 (GLUT 2): Expression in specific brain nuclei. Brain Res 638:221-226
5. Lynch RM, Tompkins LS, Brooks HL, Dunn-Meynell AA, Levin BE (2000) Localisation of glucokinase gene expression in the rat brain. Diabetes 49:693-700
6. Lee K, Dixon AK, Richardson PJ, Pinnock RD (1999) Glucose-receptive neurons in the rat ventromedial hypothalamus express KATP channels composed of Kir6.1 and SUR1 subunits. J Physiol 515:439-452
7. Ashford MLJ, Boden PR, Treherne MJ (1990) Glucose-induced excitation of hypothalamic neurones is mediated by ATP-sensitive K+ channels. Pflugers Arch 415:479-483
8. Oomura Y (1983) Glucose as a regulator of neuronal activity. Adv Metab Disord 10:31-65
9. Roberts D, Franckel S (1950) Gamma-amino butyric acid in brain. Fed Proc 9:219
10. Malaisse WJ (1992) Glucose sensing by pancreatic beta cell: the mitochondrial part. Int J Biochem 24:693-701
11. Beverley JL, Beverley MF, Meguid MM (1995) Alterations in extracellular GABA in the ventromedial hypothalamus of rats in response to acute glucoprivation. Am J Physiol 269:R1174-R1178
12. Song Z, Levin BE, McArdle JJ, Bakhos N, Routh VH (2001) Convergence of pre- and postsynaptic influences on glucosensing neurons in the ventromedial hypothalamic nucleus. Diabetes 50:2673-2681
13. Horvarth TL, Bechmann I, Nafttolin F, Kalra SP, Leranth C (1997) Heterogeneity in the neuropeptide Y-containing neurons of the rat arcuate nucleus: GABAergic and non-GABAergic subpopulations. Brain Res 756:283-286
14. Ohtani N, Ohta M, Sugano T (1997) Microdialysis study of modification of hypothalamic neurotransmitters in streptozotocin-diabetic rats. J Neurochem 69:1622-1628
15. During M, Leone P, Davis KE, Kerr D, Sherwin RS (1995) Glucose modulates rat substantia nigra GABA release in vivo via ATP-sensitive potassium channels. J Clin Invest 95:2403-2408
16. Beverley JL, Vries MG de, Beverly MF, Arseneau LM (2000) Norepinephrine mediates glucoprivic induced increase in GABA in the ventromedial hypothalamus of rats. Am J Physiol 279:R990-R996
17. Beverley JL, Vries MG de, Bouman SD, Arseneau LM (2001) Noradrenergic and GABAergic systems in the medial hypothalamus are activated during hypoglycaemia. Am J Physiol 280:R563-R569
18. Batejat DM, Lagarde DP (1999) Naps and modafinil as countermeasures for the effects of sleep deprivation on cognitive performance. Aviat Space Environ Med 70:493-498
19. Baranski JV, Pigeau RA (1997) Self-monitoring cognitive performance during sleep deprivation, effects of modafinil, d-amphetamine and placebo. J Sleep Res 6:84-91
20. Pigeau R, Naitoh P, Buguet A et al. (1995) Modafinil D-amphetamine and placebo during 64 hours of sustained mental work. Effects on mood, fatigue, cognitive performance and body temperature. J Sleep Res 4:212-228
21. Liu D, Moberg E, Kollind K, Lins PE, Adamson U, MacDonald IA (1992) Arterial arterialized venous and capillary blood glucose measurements in normal man during hyperinsulinaemic euglycaemia and hypoglycaemia. Diabetologia 35:287-290
22. Heller SR, MacDonald IA (1996) The measurement of cognitive function during acute hypoglycaemia: experimental limitations and their effect on the study of hypoglycaemia unawareness. Diabet Med 13:607-615
23. Stroop J (1935) Studies of interference in serial verbal reaction. J Exp Psychol 18:643-652
24. Jensen AR, Rohwer WD Jr (1966) The Stroop colour word test - a review. Acta Psychol 25:36-93
25. Deary IJ, Hepburn DA, MacLeod KM, Frier BM (1993) Partitioning the symptoms of hypoglycaemia using multi-sample confirmatory factor analysis. Diabetologia 36:771-777
26. MacDonald IA, Lake DM (1985) An improved method for extracting catecholamines from body fluids. J Neurosci Meth 13:239-248
27. Aguilar-Parada E, Eisentraut AM, Unger RH (1969) Pancreatic glucagon secretion in normal and diabetic subjects. Am J Med Sci 257:415-419
28. Cunnah DC, Jessop DS, Besser GM, Rees LH (1987) Measurement of circulating corticotrophin releasing factor in man. J Endocrinol 113:123-131
29. Mazlan M (1989) Development of an immunoradiometric assay for human growth hormone releasing factor and some applications. PhD thesis, University of London, UK
30. Morgan CR, Lazaro A (1963) Immunoassay of insulin: two antibody system Diabetes 12:115A
31. Tanganelli S, Perez de la Mora, Ferraro L et al. (1995) Modafinil and corticol gamma amino butyric acid outflow. Modulation by 5-hydroxytryptamine neurotoxins. Eur J Pharmacol 273:63-71
32. Lins JS, Roussel B, Akaoka H, Fort P, Debilly G, Jouvet M (1992) Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat. Brain Res 591:319-326
33. Tanganelli S, Fuxe K, Ferraro L, Janson AM, Bianchi C (1992) Inhibitory effects of the psychoactive drug modafinil on gamma-aminobutyric acid outflow from the cerebral cortex of the awake freely moving guinea pig. Naunyn-Schmiedebergs Arch Pharmacol 345:461-465
34. Buhot MC (1997) Serotonin receptors in cognitive behaviors. Curr Opin Neurobiol 7:243-254
35. Coull JT, Frith CD, Dolan RJ, Frackowiak RS, Grasby PM (1997) The neural correlates of the noradrenergic modulation of human attention, arousal and learning. Eur J Neurosci 9:589-598
36. Wisor JP, Nishino S, Sora I, Uhl GH, Mignot E, Edgar DM (2001) Dopaminergic role in stimulant-induced wakefulness. J Neurosci 21:1787-1794
37. Levin BE, Govek EK, Dunn-Meynell AA (1998) Reduced glucose-induced neuronal activation in the hypothalamus of diet-induced obese rats. Brain Res 808:317-319
38. Engber TM, Koury EJ, Dennis SA, Miller MS, Contreras PC, Bhat RV (1998) Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil. Neurosci Lett 241:95-98
39. Gold AE, MacLeod KM, Frier BM (1994) Frequency of severe hypoglycaemia in patients with type 1 diabetes with impaired awareness of hypoglycaemia. Diabetes Care 17:697-703
40. Pramming S, Thorsteinsson B, Bendston I, Binder C (1991) Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabet Med 8:217-222